Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer.
Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer.
复制标题
DOI：
--
复制
发表时间：
2000-06
期刊：
影响因子：
--
通讯作者：
A. Duncan;B. E. Merz-Demlow;Xia Xu;W. Phipps;M. Kurzer
中科院分区：
文献类型：
--
作者：
A. Duncan;B. E. Merz-Demlow;Xia Xu;W. Phipps;M. Kurzer
尿中雌马酚（异黄酮大豆苷元的代谢物）的增加与乳腺癌风险的降低有关。这种风险的降低通常被认为是异黄酮摄入量增加的结果。然而，无论摄入多少异黄酮，只有30-40%的人排泄出超过微量的雌马酚。因此，我们假设观察到的雌马酚的明显保护作用至少部分归因于雌马酚排泄者和非排泄者之间的激素差异，而这些差异在很大程度上与异黄酮摄入量无关。我们测量了14名正常绝经前妇女的血浆激素和性激素结合球蛋白（SHBG）浓度，在三个饮食周期中，她们摄入不同剂量的异黄酮（0.15、1.0和2.0 mg/kg体重/天）作为大豆分离蛋白的组成部分。将雌马酚排泄者（n = 5）与非排泄者（n = 9）的血浆激素和SHBG浓度进行比较。结果表明，即使在最低剂量下，排泄者的尿雌马酚排泄值也远远超过摄入最高剂量的非排泄者。在所有剂量下，雌马酚排泄物通常具有较低浓度的雌酮、雌酮-硫酸、睾酮、雄烯二酮、脱氢表雄酮（DHEA）、脱氢表雄酮-硫酸脱氢表雄酮和皮质醇，以及较高浓度的SHBG和黄体酮，这种激素模式总体上与降低乳腺癌风险一致。总之，雌马酚排泄与降低乳腺癌风险之间的关系可能在很大程度上反映了雌马酚排泄者具有更有利的激素谱的趋势，而不仅仅反映了异黄酮摄入量的增加。雌马酚可能是结肠细菌酶活性增加粪便类固醇排泄的标志。另外，马酚本身，即使摄入非常少量的异黄酮，也可能对调节内源性激素发挥有益作用。
Increased urinary excretion of equol, a metabolite of the isoflavone daidzein, has been associated with a reduced risk of breast cancer. This risk reduction has generally been presumed to be a consequence of increased isoflavone consumption. However, only 30-40% of the population excretes more than trace amounts of equol, regardless of isoflavone intake. Accordingly, we hypothesized that the observed apparent protective effect of equol is at least in part attributable to hormonal differences between equol excretors and non-excretors, and that these differences are largely independent of isoflavone intake. We measured plasma hormone and sex hormone binding globulin (SHBG) concentrations in 14 normally cycling premenopausal women during each of three diet periods in which they consumed differing isoflavone doses (0.15, 1.0, and 2.0 mg/kg of body weight/day) as a component of soy protein isolate. The plasma hormone and SHBG concentrations of equol excretors (n = 5) were then compared with those of the non-excretors (n = 9). Results showed that even at the lowest dose, urinary equol excretion values for excretors far exceeded those for non-excretors consuming the highest dose. At all doses, equol excretors generally had lower concentrations of estrone, estrone-sulfate, testosterone, androstenedione, dehydroepiandrosterone (DHEA), DHEA-sulfate, and cortisol and higher concentrations of SHBG and midluteal progesterone, a hormonal pattern overall consistent with lowered breast cancer risk. In conclusion, the association of equol excretion and lowered breast cancer risk may largely reflect the tendency of equol excretors to have more favorable hormonal profiles, as opposed to merely reflecting increased isoflavone intake. Equol may be a marker for the presence of colonic bacterial enzymatic activity that increases fecal steroid excretion. Alternatively, equol itself, even with very modest isoflavone intake, may exert beneficial effects on the regulation of endogenous hormones.